The hematologic disorder paroxysmal nocturnal hemoglobinuria (PNH) occurs following an acquired somatic mutation in the Piga gene within a bone marrow stem cell. The progeny of this mutated cell cannot synthesize glycosylphosphatidylinositol (GPI) anchors, with a resultant deficiency in surface expression of all GPI-linked proteins. The protean clinical manifestations of PNH presumably result from the deficiency of these GPI-linked surface proteins. To explain the observation that neutrophils are affected at a significantly higher percentage than circulating erythrocytes and to analyze the proliferative rates of erythroid production in PNH, we studied 25 patients using flow cytometry. The fluorescent dye thiazole orange was used to detect reticulocytes, and CD59 monoclonal antibody was used to identify Raritun, NJ. R.E. W. is the recipient of a James S. McDonnell Scholarship in Molecular Medicine. Address reprint requests to Russell E. Ware, MD PhD, PO BOX 2916, DUMC, Durham, NC 27710.
P AROXYSMAL NOCTURNAL hemoglobinuria (PNH)
is an acquired hematologic disorder characterized by intravascular hemolysis, venous thrombosis, and defective hematopoiesis.'.* Although PNH typically occurs in adults, it also has been described in children.* The biochemical defect in PNH has been localized to the incomplete assembly of glycosylphosphatidylinositol (GPI) anchors used for surface membrane atta~hment.'.~ Recently, mutations within the coding sequence of the Piga gene have been identified in PNH patient^.^.^ Because PNH is generally believed to be a clonal disorder,l0." it is hypothesized that a somatic mutation in the Piga gene occurs in a multipotent bone marrow (BM) stem cell; abnormal GPI-deficient progeny are generated through clonal proliferation and differentiation of the affected stem Analysis of the peripheral blood (PB) cells of PNH patients has shown that the number of circulating GPI-deficient neutrophils is typically higher than the number of affected erythrocyte^.",'^ Whether this difference reflects a true difference in the proliferative rates of BM progenitor cells for these two lineages is not known. Alternatively, the number of affected erythrocytes may be lower simply because of ongoing hemolysis and/or transfusions. Analysis of circulating reticulocytes would provide a better comparison for pro-GPI-deficient cells. In contrast to the mature circulating erythrocytes, the percentage of abnormal reticulocytes was similar to the percentage of affected neutrophils. However, the vast majority of reticulocytes was completely GPI-deficient, ie, were type 111 cells, even in patients with only modest numbers of circulating type 111 erythrocytes. In addition, greater than 5% type II reticulocytes were identified in only 3 patients, although greater than 5% type II mature erythrocytes were identified in 10 of 25 patients. The results show that the erythroid and neutrophil bone marrow precursors have an equivalent proliferative advantage in PNH. The data also have important implications for the origin of type4 erythrocytes in PNH. liferative rates. Therefore, we analyzed a large number of PNH patients with elevated circulating reticulocyte counts.
MATERIALS AND METHODS

Patients.
Twenty-five patients with PNH were studied, including 16 females and 9 males. The patients ranged in age from 14 to 64 years (mean, 33 years). All of the patients had reticulocyte counts of more than 1 S % , and only 1 had received an erythrocyte transfusion within the previous 3 months. Controls consisted of 14 healthy adult volunteers.
Reagents. Retic-COUNT (thiazole orange; TO) was purchased from Becton Dickinson (San Jose, CA). The monoclonal antibody (MoAb) lOGlO is specific for CD59 and was the gift of Dr M. Telen (Durham, NC). Nonreactive MoAb P3 was used as a negative control. Fluorescein-conjugated goat F (ab')2 antimouse IgG (GAM-FITC) was purchased from Biosource International (Camarillo, CA).
Phycoerythrin-conjugated rabbit F (ab')2 antimouse IgG (RAM-PE) was obtained from Zymed (South San Francisco, CA). Normal goat serum, normal rabbit serum, and human group AB serum were purchased from GIBCO-BRL (Grand Island, NY). All other chemicals were of reagent or chemical grades. The buffer used for washing of cells was veronal-buffered saline (GVB-EDTA), which was composed of 5.0 mmol/L sodium barbital, 0.15 m o n NaCl, 0.1 % gelatin, and 0.015 m o m EDTA (pH, 7.5).
Preparation of erythrocytes and neutrophils. Venous PB was drawn from 25 PNH patients and 14 normal controls into EDTAcontaining tubes. After centrifugation (1,500 rpm for 5 minutes) and 2 washes with GVB-EDTA, the packed cells were resuspended to 1 X 107/mL for immunophenotypic analysis. lmmunophenotype analysis. Single-color flow analysis was performed using a two-step immunophenotype assay. A total of 100 pL of washed cells were incubated with 100 pL IOGlO or P3 (1:SOO dilution ascites) for 30 minutes at room temperature (RT). The cells were then washed twice with GVB-EDTA and resuspended to 100-pL volume. A IO-pL mixture of GAM-FITC, normal goat serum, and group AB normal human serum (ratio, l:l:2.5) was added for another 30-minute incubation at RT, followed by 2 washes in GVB-EDTA. The pelleted cells were resuspended in 1.0 mL buffer and analyzed on an ORTHO-CYTORON (Ortho Diagnostics, Raritan, NJ). Erythrocytes and neutrophils were easily distinguished using side scatter and forward scatter, allowing analysis of both types of cells.
Two-color analysis was performed as above, except that RAM-PE was used as the developing antibody after incubation with 10G 10 or P3. The cell pellet was resuspended in 1.0 mL TO and was incubated for 60 minutes at RT in the dark. The cells were then immediately analyzed on the ORTHO-CYTORON, using color compensation for cross-over of fluorescence signals between the two detectors.
Statistics. Statistical analysis was performed using the Primer of Biostatistics package (McGraw-Hill, New York, NY). Statistical comparisons were performed using the Student's t-test and the Wilcoxon signed rank test.
RESULTS
Enumeration and comparison of GPI-dejcient erythrocytes and neutrophils.
Using immunophenotypic analysis of venous PB, the percentage of circulating CD59-(GPIdeficient) neutrophils and erythrocytes was quantitated in 25 PNH patients. Both partially deficient (type 11) cells and completely deficient (type 111) cells were identified in some patients, and the total number of these cells was used for statistical comparison.
As a group, the PNH patients had a mean of 34.5% type I erythrocytes, 6.1% type I1 erythrocytes, and 59.4% type 111 erythrocytes. The normal volunteers had 100% normal (type I) erythrocytes. Figure 1 shows that the percentage of affected neutrophils (81.8% ? 3.6% [mean 2 SEMI) was significantly higher than the number of PNH erythrocytes (65.5% ? 5.4%; P = .016).
Analysis of reticulocytes in PNH patients.
Although the percentage of CD59erythrocytes was significantly less than the percentage of affected neutrophils, we realized that ongoing in vivo hemolysis might lead to an accelerated loss of PNH erythrocytes and an artificially low number of circulating cells. To quantitate the rate of production of GPI-defi-cient erythroid cells more accurately, we next analyzed reticulocytes using two-color immunophenotype analysis. For our population of 25 PNH patients, the mean percentage of circulating reticulocytes was 3.9% (range, 1.6% to 7.2%). Figure 1 also shows the percentage. of GPI-deficient reticulocytes and shows that the average number of PNH reticulocytes was significantly greater than the number of PNH erythrocytes ( P < .Ool) but was not significantly different from the number of PNH neutrophils. Figure 2 shows representative examples of flow cytometry histograms for 3 patients (referred to by unique patient number [UPN]) and a control volunteer. The data include both the single-color histogram for total erythrocytes (FLI indicates that CD59 was used for identification of GPI-linked protein expression) and the double-color histogram for reticulocytes (TO indicates that thiazole orange was used for detection of reticulocytes; FL2 indicates that CD59 was Analysis of the reticulocytes in all 25 PNH patients showed that, in each case, the vast majority of reticulocytes had no expression of CDS9. even in patients with sizable proportions of circulating type I1 erythrocytes. Figure 3 shows the percentage of reticulocytes according to their level of CD59 expression for all 25 patients. An average of 86.5% 2 2.1% (mean 2 SEM) of the reticulocytes were type 111. ie, had no CD59 surface expression. Only 3.3% 2 1.38 of the reticulocytes were type I1 cells, and 10.1% 5 I .9% of the reticulocytes had normal CD59 expression. Only 3 of the patients had greater than 5% type I1 reticulocytes.
DISCUSSION
Despite numerous reports describing flow cytometry results on PB cells in PNH,"." there have been no prior studies focusing on reticulocytes in this disorder. Analysis of PNH reticulocytes is important, however, because most patients have elevated numbers of reticulocytes that represent more closely the recent erythroid output of the BM. In contrast, circulating mature erythrocytes are subject to complementmediated intravascular lysis; therefore, the percentage of abnormal erythrocytes may not accurately reflect the proliferative rates of normal and abnormal erythroid progenitor cells.
We studied 25 PNH patients with evidence of active erythropoiesis (reticulocyte count, > 1.5%) who had not received recent erythrocyte transfusions. lmmunophenotypic analysis of reticulocytes using two-color flow cytometry was an easy and accurate method of analyzing this abnormal cell population in PNH patients. TO is a 488-nm-excitable fluorescent dye that is well-suited for flow cytometry analysis and correlates well with manual determination of reticulocyte percentage.Ix The use of TO in two-color analysis of reticulocytes has been previously reported in conjunction with MoAbs against the transferrin receptor" or glycophorin-A.'" We modified this approach using the CD59 MoAb IOGlO to identify and quantitate the various abnormal reticulocyte populations in PNH.
In each patient, the vast majority of reticulocytes were type Ill cells, ie, completely GPI-deficient (Fig 3) . As a group, the 25 patients had 59.4% type Ill erythrocytes, but 86.5% of the reticulocytes were type 111 cells. This percentage of abnormal reticulocytes was similar to the percentage of abnormal circulating neutrophils, providing evidence that the proliferative rates of the erythroid and neutrophils BM precursors are probably equivalent in PNH. Furthermore, these findings suggest that premature peripheral destruction of PNH erythrocytes may account fully for the observation than most patients have significantly more GPI-deficient neutrophils than mature erythrocytes. Without GPI-linked surface proteins, PNH erythrocytes cannot remove membranebound complement or vesiculate properly," rendering them susceptible to intravascular lysis.
Because they show a paradox between the percentages of type 11 reticulocytes and type I1 mature erythrocytes, these data are also important for the understanding of the origin of type I1 cells in PNH. Only 3 of the 25 patients had greater than 5% type I1 reticulocytes (6%, IS%, and 30%. respectively), although a total of 10 patients had greater than 5% mature type 11 erythrocytes. It is reasonable to believe that type I1 reticulocytes can mature into type I1 erythrocytes, with a near-normal in vivo lifespan. However, type I1 erythrocytes were also detected in 7 patients with virtually no type I1 reticulocytes (for examples see Figs 2B and C). We currently do not have an explanation for all of these observations but propose a series of testable hypotheses. ( I ) For patients with measurable type I1 reticulocytes, the abnormal PNH clone has a missense Pigo mutation, with partial GP1 anchor formation and dim surface expression of GPI-linked proteins (see Ware et aiy for an example); (2) for patients with sizable populations of both type I1 and type 111 reticulocytes, there are 2 independent PNH clones within the BM, one with a missense Pigo mutation and the other with a Pigo mutation leading to a complete loss of function (Bessler et al" and our unpublished observations); and (3) in patients with type I1 erythrocytes but no evidence of type I1 reticulocytes, the surface expression of GPI-linked proteins derives either from the loss of expression on type I cells or from the gain of expression on type I11 cells, eg, from plasma adsorption.
Finally, these data help explain laboratory observations first reported almost 40 years ago. Several investigators noted that, when PNH erythrocytes were separated by density centrifugation, the upper portion (reticulocyte-rich) consistently had less acetylcholinesterase or more sensitivity to acidified serum or complement-mediated lysis 24.25 . . Our data show that virtually all PNH reticulocytes For personal use only. on October 31, 2017. by guest www.bloodjournal.org From
